Gosset Alpha-amylase enzyme Overview
Alpha-amylase is a calcium-dependent enzyme that hydrolyzes internal α-1,4-glycosidic bonds in starch and glycogen, producing oligosaccharides, maltose, and dextrins[1][4][7]. It is present in mammals (notably in saliva and pancreatic secretions), plants, and microorganisms, and belongs to the glycoside hydrolase family-13[1][4][6]. Human alpha-amylase exists as two major isoenzymes: salivary amylase (ptyalin) and pancreatic amylase, encoded by related genes on chromosome 1[4][7]. The enzyme’s structure includes three domains (A, B, C), an active site cleft containing key catalytic residues (Asp197, Glu233, Asp300 in human salivary amylase), and requires calcium for stability and activity[1][3]. Alpha-amylase catalyzes the initial step in complex carbohydrate digestion, with clinical significance as a marker for pancreatic and salivary gland diseases and as a therapeutic target for diabetes control via enzyme inhibition[1][4][7].
Mechanism of Action
Competitive inhibition of α-amylase to delay carbohydrate digestion and subsequent glucose absorption
Biological Functions
Disease Associations
Safety Considerations
- Hypoglycemia (when excessively inhibited in diabetes therapy)
- Gastrointestinal discomfort (flatulence, diarrhea with inhibitors)
- Allergy (rare for industrial/biotech use)
Interacting Drugs
Associated Biomarkers
| Biomarker |
|---|
| Serum amylase levels (for pancreatitis and salivary gland disorders) |
| Pancreatic amylase |
| Salivary amylase |